Concepts (126)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Macrophage Activation Syndrome | 5 | 2023 | 110 | 1.240 |
Why?
|
Coronary Aneurysm | 2 | 2023 | 237 | 0.830 |
Why?
|
Mucocutaneous Lymph Node Syndrome | 4 | 2023 | 548 | 0.770 |
Why?
|
Antirheumatic Agents | 5 | 2019 | 1329 | 0.700 |
Why?
|
Lymphohistiocytosis, Hemophagocytic | 2 | 2022 | 255 | 0.690 |
Why?
|
Systemic Inflammatory Response Syndrome | 4 | 2023 | 606 | 0.580 |
Why?
|
Withholding Treatment | 1 | 2019 | 596 | 0.520 |
Why?
|
Cyclophosphamide | 1 | 2021 | 2238 | 0.510 |
Why?
|
Rheumatology | 3 | 2022 | 575 | 0.370 |
Why?
|
Sacroiliitis | 2 | 2019 | 11 | 0.350 |
Why?
|
Biological Products | 4 | 2023 | 850 | 0.330 |
Why?
|
Glucocorticoids | 4 | 2019 | 2100 | 0.290 |
Why?
|
Uveitis | 2 | 2019 | 377 | 0.260 |
Why?
|
Methotrexate | 3 | 2019 | 1711 | 0.240 |
Why?
|
Synovial Fluid | 2 | 2022 | 394 | 0.220 |
Why?
|
Arthritis, Rheumatoid | 3 | 2023 | 3689 | 0.210 |
Why?
|
Interleukin 1 Receptor Antagonist Protein | 2 | 2020 | 296 | 0.210 |
Why?
|
Occupational Therapy | 2 | 2019 | 133 | 0.190 |
Why?
|
Interferon Type I | 1 | 2023 | 541 | 0.180 |
Why?
|
Arthritis | 2 | 2022 | 657 | 0.170 |
Why?
|
Eosinophilia | 1 | 2023 | 531 | 0.170 |
Why?
|
Physical Therapy Modalities | 2 | 2019 | 545 | 0.160 |
Why?
|
Cell Polarity | 1 | 2021 | 644 | 0.160 |
Why?
|
Adenosine Deaminase | 1 | 2019 | 239 | 0.150 |
Why?
|
Neutrophils | 2 | 2022 | 3698 | 0.150 |
Why?
|
Risk Adjustment | 1 | 2021 | 591 | 0.150 |
Why?
|
Critical Pathways | 1 | 2021 | 475 | 0.150 |
Why?
|
Transendothelial and Transepithelial Migration | 1 | 2017 | 102 | 0.140 |
Why?
|
Immunomodulation | 1 | 2020 | 540 | 0.140 |
Why?
|
Immunoglobulins, Intravenous | 1 | 2020 | 646 | 0.140 |
Why?
|
Child | 13 | 2023 | 77033 | 0.140 |
Why?
|
Consensus | 3 | 2019 | 2913 | 0.130 |
Why?
|
Isoantigens | 1 | 2017 | 568 | 0.130 |
Why?
|
Adrenal Cortex Hormones | 2 | 2020 | 1833 | 0.120 |
Why?
|
Disease Susceptibility | 1 | 2021 | 1778 | 0.120 |
Why?
|
Remission Induction | 1 | 2019 | 2378 | 0.120 |
Why?
|
Th17 Cells | 1 | 2020 | 760 | 0.110 |
Why?
|
Chemokines | 1 | 2017 | 948 | 0.110 |
Why?
|
Ophthalmology | 1 | 2019 | 504 | 0.110 |
Why?
|
Lung Diseases | 1 | 2023 | 1879 | 0.110 |
Why?
|
Anti-Inflammatory Agents, Non-Steroidal | 2 | 2019 | 2277 | 0.100 |
Why?
|
Intercellular Signaling Peptides and Proteins | 1 | 2019 | 1675 | 0.100 |
Why?
|
Cytokines | 3 | 2023 | 7298 | 0.100 |
Why?
|
Patient Education as Topic | 1 | 2021 | 2275 | 0.100 |
Why?
|
Anti-Inflammatory Agents | 1 | 2020 | 1777 | 0.090 |
Why?
|
Child, Preschool | 6 | 2023 | 40802 | 0.090 |
Why?
|
MAP Kinase Signaling System | 1 | 2017 | 1522 | 0.090 |
Why?
|
T-Lymphocytes, Regulatory | 2 | 2021 | 2986 | 0.090 |
Why?
|
Humans | 26 | 2023 | 739398 | 0.080 |
Why?
|
Adolescent | 8 | 2022 | 85405 | 0.080 |
Why?
|
Receptors, Cell Surface | 1 | 2017 | 2864 | 0.080 |
Why?
|
Quality Improvement | 2 | 2021 | 3730 | 0.070 |
Why?
|
Evidence-Based Medicine | 1 | 2019 | 3606 | 0.070 |
Why?
|
Immunosuppressive Agents | 1 | 2019 | 4143 | 0.070 |
Why?
|
Attitude of Health Personnel | 1 | 2019 | 3844 | 0.060 |
Why?
|
Infant | 3 | 2021 | 34923 | 0.060 |
Why?
|
T-Lymphocytes | 1 | 2021 | 10142 | 0.060 |
Why?
|
Diagnosis, Differential | 1 | 2019 | 12948 | 0.060 |
Why?
|
Interleukin-15 | 1 | 2023 | 182 | 0.060 |
Why?
|
Inflammation | 1 | 2022 | 10534 | 0.050 |
Why?
|
Coronavirus Infections | 1 | 2020 | 3143 | 0.050 |
Why?
|
Pneumonia, Viral | 1 | 2020 | 3248 | 0.050 |
Why?
|
HLA-DR Antigens | 1 | 2023 | 643 | 0.050 |
Why?
|
Pain Measurement | 2 | 2022 | 3419 | 0.050 |
Why?
|
Practice Guidelines as Topic | 1 | 2019 | 7274 | 0.050 |
Why?
|
Retrospective Studies | 4 | 2023 | 76631 | 0.050 |
Why?
|
Male | 10 | 2022 | 349022 | 0.040 |
Why?
|
Chemokine CXCL9 | 1 | 2019 | 129 | 0.040 |
Why?
|
Proteomics | 2 | 2023 | 3584 | 0.040 |
Why?
|
Genetic Predisposition to Disease | 1 | 2021 | 17384 | 0.040 |
Why?
|
Interleukin-1 | 1 | 2023 | 1262 | 0.040 |
Why?
|
C-Reactive Protein | 2 | 2022 | 3752 | 0.040 |
Why?
|
Pilot Projects | 2 | 2022 | 8275 | 0.040 |
Why?
|
Blood Sedimentation | 1 | 2019 | 232 | 0.040 |
Why?
|
CD8-Positive T-Lymphocytes | 2 | 2023 | 4424 | 0.040 |
Why?
|
Female | 10 | 2022 | 378853 | 0.040 |
Why?
|
Fibrin Fibrinogen Degradation Products | 1 | 2020 | 425 | 0.040 |
Why?
|
Algorithms | 1 | 2019 | 13872 | 0.040 |
Why?
|
Interleukin-18 | 1 | 2019 | 248 | 0.040 |
Why?
|
Injections, Intra-Articular | 1 | 2019 | 277 | 0.040 |
Why?
|
Interleukin-17 | 1 | 2023 | 894 | 0.040 |
Why?
|
T-Lymphocytes, Helper-Inducer | 1 | 2023 | 986 | 0.040 |
Why?
|
Dermatomyositis | 1 | 2019 | 223 | 0.040 |
Why?
|
Ferritins | 1 | 2019 | 589 | 0.040 |
Why?
|
Immunophenotyping | 1 | 2021 | 1858 | 0.040 |
Why?
|
Th1 Cells | 1 | 2021 | 1055 | 0.040 |
Why?
|
GPI-Linked Proteins | 1 | 2017 | 433 | 0.030 |
Why?
|
Fever | 1 | 2023 | 1607 | 0.030 |
Why?
|
Patient Transfer | 1 | 2022 | 763 | 0.030 |
Why?
|
Antibodies | 1 | 2023 | 2450 | 0.030 |
Why?
|
Interleukin-10 | 1 | 2020 | 1199 | 0.030 |
Why?
|
Extracellular Signal-Regulated MAP Kinases | 1 | 2017 | 625 | 0.030 |
Why?
|
src-Family Kinases | 1 | 2017 | 549 | 0.030 |
Why?
|
Autoantibodies | 1 | 2023 | 2020 | 0.030 |
Why?
|
Sequence Analysis, RNA | 1 | 2021 | 1994 | 0.030 |
Why?
|
Interferon-gamma | 1 | 2022 | 3193 | 0.030 |
Why?
|
Counseling | 1 | 2021 | 1526 | 0.030 |
Why?
|
Natriuretic Peptide, Brain | 1 | 2020 | 1557 | 0.030 |
Why?
|
Knee Joint | 1 | 2021 | 1676 | 0.030 |
Why?
|
Host-Pathogen Interactions | 1 | 2021 | 1476 | 0.030 |
Why?
|
Reference Values | 1 | 2019 | 4983 | 0.030 |
Why?
|
Single-Cell Analysis | 1 | 2021 | 2141 | 0.020 |
Why?
|
Interleukin-6 | 1 | 2020 | 3194 | 0.020 |
Why?
|
B-Lymphocytes | 1 | 2023 | 4663 | 0.020 |
Why?
|
Risk Factors | 3 | 2023 | 71974 | 0.020 |
Why?
|
CD4-Positive T-Lymphocytes | 1 | 2021 | 4374 | 0.020 |
Why?
|
Massachusetts | 1 | 2021 | 8669 | 0.020 |
Why?
|
DNA Methylation | 1 | 2021 | 4269 | 0.020 |
Why?
|
Lupus Erythematosus, Systemic | 1 | 2019 | 2091 | 0.020 |
Why?
|
Phosphorylation | 1 | 2017 | 8416 | 0.020 |
Why?
|
Pain | 1 | 2021 | 4923 | 0.020 |
Why?
|
Young Adult | 2 | 2022 | 56255 | 0.020 |
Why?
|
Incidence | 1 | 2023 | 20913 | 0.020 |
Why?
|
Sensitivity and Specificity | 1 | 2019 | 14740 | 0.020 |
Why?
|
Phenotype | 1 | 2022 | 16301 | 0.020 |
Why?
|
Case-Control Studies | 1 | 2021 | 21694 | 0.010 |
Why?
|
Mass Screening | 1 | 2019 | 5265 | 0.010 |
Why?
|
Predictive Value of Tests | 1 | 2019 | 15036 | 0.010 |
Why?
|
Aging | 1 | 2022 | 8613 | 0.010 |
Why?
|
Treatment Outcome | 2 | 2019 | 62693 | 0.010 |
Why?
|
Adult | 3 | 2020 | 213394 | 0.010 |
Why?
|
Pandemics | 1 | 2020 | 8274 | 0.010 |
Why?
|
Risk Assessment | 1 | 2021 | 23294 | 0.010 |
Why?
|
Mice | 1 | 2022 | 81002 | 0.010 |
Why?
|
Magnetic Resonance Imaging | 1 | 2021 | 35326 | 0.010 |
Why?
|
Animals | 1 | 2022 | 168368 | 0.010 |
Why?
|
Concepts
(126)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(61)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_